首页> 外文期刊>The American Journal of Cardiology >Comparison of frequency of radial artery occlusion after 4fr versus 6fr transradial coronary intervention (from the novel angioplasty using coronary accessor trial)
【24h】

Comparison of frequency of radial artery occlusion after 4fr versus 6fr transradial coronary intervention (from the novel angioplasty using coronary accessor trial)

机译:经fr动脉冠状动脉介入治疗4fr与6fr radial动脉闭塞的频率比较(来自使用冠状动脉附件的新型血管成形术)

获取原文
获取原文并翻译 | 示例
       

摘要

The frequency of radial artery occlusion was compared between patients receiving 4Fr versus 6Fr transradial coronary interventions (TRIs) in an open-label randomized trial (ClinicalTrials.gov identifier: NCT00815997). The primary outcome measure was radial artery occlusion on the day after TRI. The secondary outcome measures were the procedural success, major advanced cardiac events, access site-related complications, procedural times, fluoroscopy times, and contrast dye usage. A total of 160 patients were included. The procedure was successful in 79 of 80 patients (99%) in both groups. Whereas the 4Fr group showed no access site-related complications, the 6Fr developed 5 (6%), including 3 radial artery occlusions and 2 bleedings (1 radial artery perforation and 1 massive hematoma; p = 0.02). Although the radial artery occlusion rate was lower in the 4Fr versus the 6Fr groups, the difference was not significant (0% vs 4%, p = 0.08). The mean hemostasis time was significantly shorter in the 4Fr than in the 6Fr groups (237 ± 105 vs 320 ± 238 minutes, p = 0.007). In conclusion, these findings suggest that 4Fr TRI may become a less invasive alternative to 6Fr TRI in treating coronary artery diseases.
机译:在一项开放标签的随机试验(ClinicalTrials.gov标识符:NCT00815997)中,比较了接受4Fr和6Fr trans动脉冠状动脉介入治疗(TRIs)的患者之间的radial动脉闭塞频率。主要结局指标为TRI后第二天的radial动脉闭塞。次要结果指标是程序成功,主要的严重心脏事件,进入部位相关的并发症,程序时间,透视检查时间和对比染料的使用。总共包括160名患者。两组中有79名患者(99%)手术成功。 4Fr组未显示出入部位相关并发症,而6Fr组出现5例(6%),包括3例radial动脉闭塞和2例出血(1例artery动脉穿孔和1例大血肿; p = 0.02)。尽管4Fr组的the动脉闭塞率低于6Fr组,但差异不显着(0%对4%,p = 0.08)。 4Fr组的平均止血时间明显短于6Fr组(237±105 vs 320±238分钟,p = 0.007)。总之,这些发现表明,在治疗冠状动脉疾病中,4Fr TRI可能成为6Fr TRI的侵入性较小的替代药物。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号